Chemoinformaics analysis of Caffeic acid 3-glucoside
| Molecular Weight | 342.3 | nRot | 5 |
| Heavy Atom Molecular Weight | 324.156 | nRig | 14 |
| Exact Molecular Weight | 342.095 | nRing | 2 |
| Solubility: LogS | -1.106 | nHRing | 1 |
| Solubility: LogP | -0.324 | No. of Aliphatic Rings | 1 |
| Acid Count | 1 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 42 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 24 | No. of Aromatic Carbocycles | 1 |
| nHetero | 9 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 9 | No. of Arom Bond | 6 |
| nHA | 8 | APOL | 44.2703 |
| nHD | 6 | BPOL | 22.3977 |
| QED | 0.357 |
| Synth | 3.63 |
| Natural Product Likeliness | 2.069 |
| NR-PPAR-gamma | 0.017 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.426 |
| HIA | 0.835 |
| CACO-2 | -6.278 |
| MDCK | 0.0000189 |
| BBB | 0.256 |
| PPB | 0.817791 |
| VDSS | 0.28 |
| FU | 0.205644 |
| CYP1A2-inh | 0.125 |
| CYP1A2-sub | 0.024 |
| CYP2c19-inh | 0.019 |
| CYP2c19-sub | 0.048 |
| CYP2c9-inh | 0.01 |
| CYP2c9-sub | 0.091 |
| CYP2d6-inh | 0.013 |
| CYP2d6-sub | 0.133 |
| CYP3a4-inh | 0.015 |
| CYP3a4-sub | 0.008 |
| CL | 1.703 |
| T12 | 0.903 |
| hERG | 0.044 |
| Ames | 0.154 |
| ROA | 0.251 |
| SkinSen | 0.88 |
| Carcinogencity | 0.101 |
| EI | 0.119 |
| Respiratory | 0.062 |
| NR-Aromatase | 0.016 |
| Antiviral | Yes |
| Prediction | 0.661994 |